1981
DOI: 10.1016/0002-9610(81)90190-2
|View full text |Cite
|
Sign up to set email alerts
|

Gastrin and gastric acid secretion in renal failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0
1

Year Published

1988
1988
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(23 citation statements)
references
References 19 publications
0
22
0
1
Order By: Relevance
“…61 As a result, gastric atrophy progresses, accompanied by increased pH, and finally H. pylori are not able to live in gastric mucosa. 62 In this study, there was no significant difference in the prevalence of H. pylori infection between patients with normal renal function and patients receiving less than 1 year of dialysis treatment. Therefore, urea concentration and antibiotic usage are unlikely contributors to decrease the prevalence of infection.…”
Section: Discussionmentioning
confidence: 48%
“…61 As a result, gastric atrophy progresses, accompanied by increased pH, and finally H. pylori are not able to live in gastric mucosa. 62 In this study, there was no significant difference in the prevalence of H. pylori infection between patients with normal renal function and patients receiving less than 1 year of dialysis treatment. Therefore, urea concentration and antibiotic usage are unlikely contributors to decrease the prevalence of infection.…”
Section: Discussionmentioning
confidence: 48%
“…Possible factors that play a role in disturbed gastric motility are increased levels of GI hormones, [30][31][32] such as cholecystokinin and gastrin, which modulate GI motility, retention of uremic toxin, and autonomic nervous system dysfunction. 33,34 Several cytokines that appear in patients with CRF, as well as their retention of uremic toxin, may affect the autonomic and enteric nervous system.…”
Section: Discussionmentioning
confidence: 99%
“…Various factors affect gastric motility in patients with CRF. Among these may be the increased levels of some GI hormones (Taylor et al, 1980;Wesdorp et al, 1981;Sirinek et al, 1984), several kinds of uremic toxin retention (Jones et al, 1969;Nakamura et al, 1990;DeDeyn et al, 1995;Anderstam et al, 1996), and a number of cytokines (Herbelin et al, 1991;Brockhaus et al, 1992;Kimmel et al, 1998;king et al, 1998) that appear in CRF patients. Some kinds of uremic toxin that can induce GI symptoms such as anorexia and bloating is excluded after the hemodialysis.…”
Section: Discussionmentioning
confidence: 99%